Tango Therapeutics, Inc. remains a high-risk, high-reward biotech, focused on PRMT5 inhibitors for MTAP-deleted cancers—a large, underserved market opportunity. Disappointing clinical data last ...

Air Canada's Tango low-fare airline this spring will add several new destinations to its network. Effective April 1, daily Tango service will start on Regina/Saskatoon-Toronto and Thunder Bay-Toronto.